author-photo

Ana Sebio

University of Southern California

60

Papers

468

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II.

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (1)
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part I.

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (0)
Inflammatory indexes neutrophils/lymphocytes, platelets/lymphocytes and red-cell distribution width (RDW) as prognostic biomarkers in advanced solitary fibrous tumors (SFT) treated with pazopanib: Correlative study of GEIS-32 trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of dystrophin expression by immunohistochemistry as a prognostic factor in leiomyosarcomas (LMS).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Systemic Treatment in Advanced Phyllodes Tumor of the Breast: A Multi-Institutional European Retrospective Case-Series Analyses

2021
Show All
- Source
- Cite
- Save
Citations (0)
ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients

2020 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (4)
IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype

2019 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (15)
Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer

2018 Pharmacogenomics Journal
Show All
- Source
- Cite
- Save
Citations (4)
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials.

2018 Pharmacogenomics Journal
Show All
- Source
- Cite
- Save
Citations (2)